D-1025-2018 Class II Terminated
FDA drug recall D-1025-2018 was initiated by West-Ward Columbus Inc on Jul 24, 2018 and is designated Class II. Reason for recall: Failed Dissolution Specifications: The recall status is terminated (terminated Apr 29, 2020). Affected quantity: 29048 500-count bottles (14,524,000 tablets).
Recall details
- Product Type
- Drugs
- Report Date
- Aug 8, 2018
- Initiation Date
- Jul 24, 2018
- Termination Date
- Apr 29, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 29048 500-count bottles (14,524,000 tablets)
Product description
Doxycycline Hyclate Tablets, USP, 100 mg*. 500-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724. NDC# 0143-2112-05.
Reason for recall
Failed Dissolution Specifications:
Distribution pattern
Nationwide in the USA.
Code information
Lot# 71545A, Expiry date: 07/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1025-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026